Trial
NCT06555601
A First-in-human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UCB3101 in Healthy Participants
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
UCB Biopharma SRL
Collaborators
—
Condition
Healthy Participants
Intervention
UCB3101
Why stopped
sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-12